
Vijay Kumar
Stock Analyst at Evercore ISI
(4.52)
# 1,079
Out of 5,144 analysts
556
Total ratings
56%
Success rate
7.9%
Average return
Main Sectors:
Stocks Rated by Vijay Kumar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Reiterated: Buy | $100 → $112 | $105.43 | +6.23% | 35 | Nov 5, 2026 | |
| RVTY Revvity | Reiterated: Buy | $126 → $180 | $147.79 | +21.79% | 22 | Nov 3, 2026 | |
| ILMN Illumina | Reiterated: Buy | $200 → $275 | $202.61 | +35.73% | 24 | Oct 30, 2026 | |
| NVCR NovoCure | Reiterated: Buy | $20 | $11.14 | +79.53% | 22 | Oct 30, 2026 | |
| SYK Stryker | Reiterated: Buy | $350 → $320 | $317.54 | +0.77% | 28 | Oct 30, 2026 | |
| AVTR Avantor | Reiterated: Hold | $14 → $17 | $15.18 | +11.99% | 20 | Oct 28, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $112 → $120 | $104.71 | +14.60% | 26 | Oct 23, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $148 → $172 | $172.22 | -0.13% | 19 | Aug 27, 2026 | |
| ENOV Enovis | Reiterated: Buy | $32 | $27.22 | +17.56% | 15 | Aug 7, 2026 | |
| IRTC iRhythm Holdings | Reiterated: Buy | $150 → $165 | $89.67 | +84.02% | 6 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $45.81 | -23.60% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $26 | $19.94 | +30.39% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $23 | $23.78 | -3.28% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $410 → $420 | $449.78 | -6.62% | 16 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 | $20.83 | -18.39% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $55 | $43.03 | +27.82% | 28 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $84 | $81.84 | +2.64% | 14 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $24 | $25.76 | -6.83% | 20 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 | $215.42 | -16.44% | 17 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 → $230 | $225.77 | +1.87% | 17 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $200 | $143.28 | +39.59% | 6 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $480 → $430 | $430.53 | -0.12% | 44 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $106 → $105 | $102.32 | +2.62% | 22 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,425 → $1,350 | $1,712.95 | -21.19% | 17 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $335 → $320 | $319.11 | +0.28% | 8 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $575 → $570 | $686.79 | -17.01% | 22 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $56 → $102 | $112.00 | -8.93% | 11 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $110 | $102.09 | +7.75% | 24 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $350 → $320 | $414.12 | -22.73% | 2 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $3.51 | n/a | 9 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $150 | $134.60 | n/a | 14 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 → $2.5 | $0.5616 | n/a | 4 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93 | $268.07 | n/a | 1 | Nov 9, 2022 |
Edwards Lifesciences
Nov 5, 2026
Reiterated: Buy
Price Target: $100 → $112
Current: $105.43
Upside: +6.23%
Revvity
Nov 3, 2026
Reiterated: Buy
Price Target: $126 → $180
Current: $147.79
Upside: +21.79%
Illumina
Oct 30, 2026
Reiterated: Buy
Price Target: $200 → $275
Current: $202.61
Upside: +35.73%
NovoCure
Oct 30, 2026
Reiterated: Buy
Price Target: $20
Current: $11.14
Upside: +79.53%
Stryker
Oct 30, 2026
Reiterated: Buy
Price Target: $350 → $320
Current: $317.54
Upside: +0.77%
Avantor
Oct 28, 2026
Reiterated: Hold
Price Target: $14 → $17
Current: $15.18
Upside: +11.99%
Abbott Laboratories
Oct 23, 2026
Reiterated: Buy
Price Target: $112 → $120
Current: $104.71
Upside: +14.60%
Agilent Technologies
Aug 27, 2026
Reiterated: Buy
Price Target: $148 → $172
Current: $172.22
Upside: -0.13%
Enovis
Aug 7, 2026
Reiterated: Buy
Price Target: $32
Current: $27.22
Upside: +17.56%
iRhythm Holdings
Aug 7, 2026
Reiterated: Buy
Price Target: $150 → $165
Current: $89.67
Upside: +84.02%
Aug 6, 2026
Reiterated: Buy
Price Target: $35
Current: $45.81
Upside: -23.60%
Aug 6, 2026
Reiterated: Buy
Price Target: $25 → $26
Current: $19.94
Upside: +30.39%
Aug 5, 2026
Reiterated: Buy
Price Target: $30 → $23
Current: $23.78
Upside: -3.28%
Aug 5, 2026
Reiterated: Buy
Price Target: $410 → $420
Current: $449.78
Upside: -6.62%
Jul 30, 2026
Reiterated: Hold
Price Target: $17
Current: $20.83
Upside: -18.39%
Jul 30, 2026
Reiterated: Buy
Price Target: $65 → $55
Current: $43.03
Upside: +27.82%
Jul 30, 2026
Reiterated: Buy
Price Target: $80 → $84
Current: $81.84
Upside: +2.64%
Jul 6, 2026
Reiterated: Buy
Price Target: $22 → $24
Current: $25.76
Upside: -6.83%
Jul 6, 2026
Reiterated: Buy
Price Target: $180
Current: $215.42
Upside: -16.44%
Jul 6, 2026
Reiterated: Buy
Price Target: $225 → $230
Current: $225.77
Upside: +1.87%
Jul 6, 2026
Reiterated: Buy
Price Target: $160 → $200
Current: $143.28
Upside: +39.59%
Jul 6, 2026
Reiterated: Hold
Price Target: $480 → $430
Current: $430.53
Upside: -0.12%
Jul 6, 2026
Reiterated: Buy
Price Target: $106 → $105
Current: $102.32
Upside: +2.62%
Jul 6, 2026
Reiterated: Buy
Price Target: $1,425 → $1,350
Current: $1,712.95
Upside: -21.19%
Jul 6, 2026
Reiterated: Buy
Price Target: $335 → $320
Current: $319.11
Upside: +0.28%
Jul 6, 2026
Reiterated: Buy
Price Target: $575 → $570
Current: $686.79
Upside: -17.01%
Jul 6, 2026
Downgraded: Hold
Price Target: $56 → $102
Current: $112.00
Upside: -8.93%
Jul 6, 2026
Reiterated: Buy
Price Target: $120 → $110
Current: $102.09
Upside: +7.75%
Feb 3, 2026
Reiterated: Buy
Price Target: $350 → $320
Current: $414.12
Upside: -22.73%
May 19, 2025
Reiterated: Hold
Price Target: $3
Current: $3.51
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: $160 → $150
Current: $134.60
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $2 → $2.5
Current: $0.5616
Upside: n/a
Nov 9, 2022
Reiterated: Buy
Price Target: $93
Current: $268.07
Upside: n/a